Dr. Amr Moursi · Efficacy and safety of stereotactic radiosurgery versus whole brain radiotherapy for the treatment of brain metastasis: a systematic review and meta-analysis
Follow
Article1 min read·Published Jul 2026

Efficacy and safety of stereotactic radiosurgery versus whole brain radiotherapy for the treatment of brain metastasis: a systematic review and meta-analysis

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jul 2026 · 1 min read

In brief

In brief

This meta-analysis comparing stereotactic radiosurgery (SRS) to whole brain radiotherapy for brain metastases found that SRS improves survival and local control while better preserving cognitive function and quality of life, though with higher distant brain recurrence rates. SRS is recommended as preferred treatment for high-risk patients based on its superior safety profile.

Written by the GCMD Library team from the article.

Amr Moursi

SRS enhances survival and local tumor control but is associated with an increased risk of distant brain recurrences. Due to its safety profile, SRS is recommended for high-risk patients, as it preserves short-term quality of life and maintains long-term cognitive function.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →